Czech National Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Czech National Bank’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,888	Closed	-$1.06M	–	506
2024 Q2	$1.06M	Buy	3,888 +206	+6%	+$59.9K	0.01%	500
2024 Q1	$1.27M	Buy	3,682 +17	+0.5%	+$5.59K	0.02%	497
2023 Q4	$1.18M	Buy	3,665 +15	+0.4%	+$4.7K	0.02%	494
2023 Q3	$1.31M	Buy	3,650 +1,123	+44%	+$433K	0.02%	481
2023 Q2	$958K	Sell	2,527 -10	-0.4%	-$4.07K	0.02%	480
2023 Q1	$1.22M	Buy	2,537 +17	+0.7%	+$7.96K	0.03%	450
2022 Q4	$1.06M	Buy	2,520 +29	+1%	+$11.7K	0.03%	460
2022 Q3	$1.04M	Buy	+2,491	New	+$1.24M	0.03%	453

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Czech National Bank's BIO Position: Q3 2024 in Review

Czech National Bank sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 3,888 shares — an estimated $1.06M sold.

Czech National Bank first reported a position in BIO in Q3 2022 and held it in 8 quarters. The position peaked at $1.31M in Q3 2023. 438 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

Czech National Bank reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
Czech National Bank sold 3,888 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $1.06M.
Czech National Bank first reported a position in Bio-Rad Laboratories Class A in Q3 2022 and held it in 8 quarters.
Czech National Bank's Bio-Rad Laboratories Class A position peaked at $1.31M in Q3 2023.
438 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on Czech National Bank's 13F filing for Q3 2024, filed 3 Oct 2024.